PharmD_Rodriguez said:LarryQC_SD said: ...compounded vs brand cost and coverage...
Bookmarking. The distinction being drawn above is the one nobody else makes. Taking it to my next appointment.
Clinical perspective, offered as context rather than as advice.
Insurance update relevant to cost and coverage: I just got my prior auth approved through Aetna after 1 attempts.
What finally worked: a letter from my endocrinologist documenting BMI history (>3 years), failed diet attempts, comorbidities (PCOS + insulin resistance), and referencing the SURMOUNT trial data.
If your PA keeps getting denied, don't give up. Request a peer-to-peer review between your doctor and the insurance medical director. That's what finally broke through for me.
PedsEndoPhilly said:Telehealth prescriber review for cost and coverage: I've used 2 different telehealth platforms to get my GLP-1 prescription.
My insurance denied my PA related to cost and coverage. Has anyone successfully appealed? I'm considering going compounded instead.
Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.
Shop Reference StandardsB12Beth said:Denials are usually procedural rather than clinical, and the order that works reflects that.
Insurance coverage hack for cost and coverage: if your insurance denies brand Wegovy/Ozempic, consider these alternatives:
Don't let cost prevent access to effective treatment. There are options at every price point.
Moderator note: good thread. Keeping it here rather than moving it, because the question is general enough to be useful. No action needed from anybody.